Literature DB >> 25376762

The medical director and quality requirements in the dialysis facility.

Brigitte Schiller1.   

Abstract

Four decades after the successful implementation of the ESRD program currently providing life-saving dialysis therapy to >430,000 patients, the definitions of and demands for a high-quality program have evolved and increased at the same time. Through substantial technological advances ESRD care improved, with a predominant focus on the technical aspects of care and the introduction of medications such as erythropoiesis-stimulating agents and active vitamin D for anemia and bone disease management. Despite many advances, the size of the program and the increasingly older and multimorbid patient population have contributed to continuing challenges for providing consistently high-quality care. Medicare's Final Rule of the Conditions for Coverage (April 2008) define the medical director of the dialysis center as the leader of the interdisciplinary team and the person ultimately accountable for quality, safety, and care provided in the center. Knowledge and active leadership with a hands-on approach in the quality assessment and performance improvement process (QAPI) is essential for the achievement of high-quality outcomes in dialysis centers. A collaborative approach between the dialysis provider and medical director is required to optimize outcomes and deliver evidence-based quality care. In 2011 the Centers for Medicare & Medicaid Services introduced a pay-for-performance program-the ESRD quality incentive program (QIP)- with yearly varying quality metrics that result in payment reductions in subsequent years when targets are not achieved during the performance period. Success with the QIP requires a clear understanding of the structure, metrics, and scoring methods. Information on achievement and nonachievement is publicly available, both in facilities (through the facility performance score card) and on public websites (including Medicare's Dialysis Facility Compare). By assuming the leadership role in the quality program of dialysis facilities, the medical director is given an important opportunity to improve patients' lives and effect true change in a patient population dealing with a very challenging chronic disease. This article in the series on the role of the medical director summarizes the medical director's specific role in the quality improvement process in the dialysis facility and the associated requirements and programs, including QAPI and QIP.
Copyright © 2015 by the American Society of Nephrology.

Entities:  

Keywords:  Medical Director; QAPI; QIP; dialysis; quality improvement

Mesh:

Year:  2014        PMID: 25376762      PMCID: PMC4348682          DOI: 10.2215/CJN.05810614

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  7 in total

1.  Dialysis at a crossroads--Part II: A call for action.

Authors:  Thomas F Parker; Barry M Straube; Allen Nissenson; Raymond M Hakim; Theodore I Steinman; Richard J Glassock
Journal:  Clin J Am Soc Nephrol       Date:  2012-04-12       Impact factor: 8.237

Review 2.  Performance measurement in chronic kidney disease.

Authors:  Kimberly A Smith; Rodney A Hayward
Journal:  J Am Soc Nephrol       Date:  2011-02       Impact factor: 10.121

3.  Improving outcomes for ESRD patients: shifting the quality paradigm.

Authors:  Allen R Nissenson
Journal:  Clin J Am Soc Nephrol       Date:  2013-11-07       Impact factor: 8.237

4.  The triple aim: care, health, and cost.

Authors:  Donald M Berwick; Thomas W Nolan; John Whittington
Journal:  Health Aff (Millwood)       Date:  2008 May-Jun       Impact factor: 6.301

5.  Conclusions, consensus, and directions for the future.

Authors:  Thomas F Parker; Richard J Glassock; Theodore I Steinman
Journal:  Clin J Am Soc Nephrol       Date:  2009-12       Impact factor: 8.237

6.  A piece of my mind. Filling buckets.

Authors:  Matthew J Press; Timothy J Judson; Allan S Detsky
Journal:  JAMA       Date:  2014-05-14       Impact factor: 56.272

7.  Dialysis at a crossroads: 50 years later.

Authors:  Thomas Parker; Raymond Hakim; Allen R Nissenson; Theodore Steinman; Richard J Glassock
Journal:  Clin J Am Soc Nephrol       Date:  2010-12-09       Impact factor: 8.237

  7 in total
  5 in total

1.  Integrating Quality Improvement Education into the Nephrology Curricular Milestones Framework and the Clinical Learning Environment Review.

Authors:  Lisa K Prince; Dustin J Little; Katherine I Schexneider; Christina M Yuan
Journal:  Clin J Am Soc Nephrol       Date:  2016-11-10       Impact factor: 8.237

2.  Optimal Role of the Nephrologist in the Intensive Care Unit.

Authors:  D J Askenazi; Michael Heung; Michael J Connor; Rajit K Basu; Jorge Cerdá; Kent Doi; Jay L Koyner; Azra Bihorac; Ladan Golestaneh; Anitha Vijayan; Mark D Okusa; Sarah Faubel
Journal:  Blood Purif       Date:  2016-12-03       Impact factor: 2.614

3.  How to Use Quality Improvement Tools in Clinical Practice: A Primer for Nephrologists.

Authors:  Christopher T Chan; Glenn M Chertow; Gihad Nesrallah; Chaim M Bell
Journal:  Clin J Am Soc Nephrol       Date:  2016-03-25       Impact factor: 8.237

4.  Systems Thinking and Leadership: How Nephrologists Can Transform Dialysis Safety to Prevent Infections.

Authors:  Leslie P Wong
Journal:  Clin J Am Soc Nephrol       Date:  2018-03-22       Impact factor: 8.237

Review 5.  Continuous quality improvement in nephrology: a systematic review.

Authors:  Julie Wright Nunes; F Jacob Seagull; Panduranga Rao; Jonathan H Segal; Nandita S Mani; Michael Heung
Journal:  BMC Nephrol       Date:  2016-11-24       Impact factor: 2.388

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.